Cargando…
Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
Novel anticancer medicines, including targeted therapies and immune checkpoint inhibitors, have greatly improved the management of cancers. However, both conventional and new anticancer treatments induce cardiac adverse effects, which remain a critical issue in clinic. Cardiotoxicity induced by anti...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993588/ https://www.ncbi.nlm.nih.gov/pubmed/32039239 http://dx.doi.org/10.3389/fcvm.2019.00194 |